Shandong Buchang Pharmaceuticals (SHA:603858) obtained drug registration certificates in China for sitagliptin phosphate and montelukast sodium.
Sitagliptin phosphate is used for controlling blood sugar, while montelukast sodium is used for preventing asthma symptoms, according to a Friday filing with the Shanghai bourse.
Shares of the pharmaceutical company were down 1% in recent trade.